These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15274844)

  • 1. [Drug-eluting stents: efficacy, effectiveness, efficiency and evidence].
    Lázaro y de Mercado P
    Rev Esp Cardiol; 2004 Jul; 57(7):608-12. PubMed ID: 15274844
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-coated stents boost benefits of angioplasty. These tiny devices keep unclogged arteries open but don't prevent blockages from arising in other heart arteries.
    Harv Heart Lett; 2004 Jan; 14(5):4. PubMed ID: 14734293
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-eluting balloons: what is their place on the interventionalist's shelf?
    Banning AP; Lim CC
    Heart; 2010 Aug; 96(16):1257-8. PubMed ID: 20659942
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rush is on to acquire drug-eluting stents.
    Hosp Mater Manage; 2003 Jun; 28(6):2, 11. PubMed ID: 12825380
    [No Abstract]   [Full Text] [Related]  

  • 6. Are drug-eluting stents cost-effective? It depends on whom you ask.
    Ryan J; Cohen DJ
    Circulation; 2006 Oct; 114(16):1736-43; discussion 1744. PubMed ID: 17043177
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents.
    Jiménez-Quevedo P; Sabaté M
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):635-46. PubMed ID: 16076274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
    Gil RJ
    Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
    [No Abstract]   [Full Text] [Related]  

  • 10. TCT Daily: ZOMAXX I--mixed results with zotarolimus-eluting stent.
    J Interv Cardiol; 2007 Feb; 20(1):35. PubMed ID: 17300399
    [No Abstract]   [Full Text] [Related]  

  • 11. [PTCA with drug eluting stent. 90% fewer restenoses in high risk patients].
    MMW Fortschr Med; 2004 Aug; 146(33-34):53. PubMed ID: 15526636
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiology patient page. Drug-eluting stents.
    Maisel WH; Laskey WK
    Circulation; 2007 May; 115(17):e426-7. PubMed ID: 17470700
    [No Abstract]   [Full Text] [Related]  

  • 13. Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.
    Noordeloos AM; Soullié T; Duckers HJ; Serruys PW
    Endothelium; 2006; 13(6):431-9. PubMed ID: 17169775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another battlefield for drug-eluting coronary stents: chronic kidney disease.
    Celik T; Iyisoy A; Yilmaz MI; Kardesoglu E; Isik E
    Int J Cardiol; 2009 Apr; 133(2):245-6; author reply 247-8. PubMed ID: 18055042
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.
    Birkenhauer P; Yang Z; Gander B
    J Pharm Pharmacol; 2004 Nov; 56(11):1339-56. PubMed ID: 15525440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
    Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
    Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents to transform cardiovascular medicine.
    Morrow T
    Manag Care; 2003 Jul; 12(7):47-50. PubMed ID: 12891955
    [No Abstract]   [Full Text] [Related]  

  • 19. [Do vascular stents solve the restenosis problem? You are too optimistic!].
    Kleinertz K
    MMW Fortschr Med; 2002 Aug; 144(31-32):12. PubMed ID: 12422722
    [No Abstract]   [Full Text] [Related]  

  • 20. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.